FDA Approved: ONDANSETRON — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for a generic ondansetron product from Heritage Pharmaceuticals (Avet) under the ANDA process.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting
• Postoperative Nausea and Vomiting
• Radiation-induced Nausea and Vomiting

Drugs mentioned

• Ondansetron (ondansetron)

Snippet

SUPPL AP for ONDANSETRON (ONDANSETRON)